Hepatocellular Carcinoma in HIV-infected Patients

Study ID
NCT02785835

Study type
Observational

Study phase

Study status
Completed

Trial Acronym

GEHEP-002

Trial Summary

Observational study. All HIV-infected patients who have been diagnosed of hepatocellular carcinoma (HCC), following the American Association for the Study of Liver Diseases (AASLD) criteria, in the participant centers are included. Epidemiological, clinical and laboratory data are collected. The clinical and epidemiological characteristics of HCC cases will be analyzed. The efficacy and outcomes after modalities of HCC therapy will be assessed. Mortality and its predictors will be also assessed. In those cases infected by hepatitis C virus (HCV), the impact of HCV therapy on outcomes will be analysed.

More informations

Trial Starting Date

May 31,2014

Requirements

Gender All
Minimum age 18 Years
Maximum age N/A

Enrollement Limit

477